Recepta Biopharma
PrivateLast Round
VC Round
Jul 26, 2012
Total Funding Raised
$3.5M
Company Overview
Recepta Biopharma operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a VC Round in July 2012.
Recepta Biopharma is a biotechnology company that researches and develops monoclonal antibodies and peptides for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recepta Biopharma Comparables
Compare Recepta Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImunoTera Soluções Terapêuticas | 74% | |
| Andes Biotechnologies | 74% | |
| Celluris | 68% |
For institutional investors. Book with your work email.
Recepta Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 26, 2012 | ||||
| Grant | Jun 1, 2007 |
For institutional investors. Book with your work email.
Recepta Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Financiadora de Estudos e Projetos | VC Round, Grant |
| FAPESP | Grant |
| BNDES Participações S.A. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 33% MoM, reaching 3.7K.
- Jun 1, 2007
Secured $3.16M in grant funding from Financiadora de Estudos e Projetos.
For institutional investors. Book with your work email.
Recepta Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Recepta Biopharma's valuation, stock price, and market status.
Is Recepta Biopharma a public or private company?
Recepta Biopharma is a private company.
What is the current stock price of Recepta Biopharma?
Recepta Biopharma is a private company, so its shares have no public market price. Caplight tracks Recepta Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Recepta Biopharma worth (valuation)?
Valuation information for Recepta Biopharma is not publicly available.
Can I buy Recepta Biopharma stock?
Recepta Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Recepta Biopharma's last funding round?
Recepta Biopharma's most recent funding round was VC Round on July 26, 2012.
Who are the main investors in Recepta Biopharma?
Key investors in Recepta Biopharma include BNDES Participações S.A..
Will Recepta Biopharma IPO soon?
No public IPO plans have been announced for Recepta Biopharma.
How can I track Recepta Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Recepta Biopharma's shares on secondary markets.